GAMMA Investing’s Nautilus Biotechnolgy NAUT Stock Holding History

GAMMA Investing’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.04K	Buy	+3,547	New	+$4.21K	﹤0.01%	3643
2024 Q3	–	Sell	-44	Closed	-$103	–	3635
2024 Q2	$103	Sell	44 -61	-58%	-$159	﹤0.01%	3405
2024 Q1	$309	Hold	105	–	–	﹤0.01%	3175
2023 Q4	$292	Buy	+105	New	+$300	﹤0.01%	3064

Other funds holding NAUT

WPC

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

GAMMA Investing's NAUT Position: Q3 2026 in Review

GAMMA Investing opened a new position in Nautilus Biotechnolgy (NAUT) in Q3 2026: 3,547 shares worth $5.04K. The stake represents ﹤0.01% of the portfolio and ranks #3643 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in NAUT as recently as Q2 2024.

GAMMA Investing first reported a position in NAUT in Q4 2023 and has held it in 4 quarters since. 2 funds tracked by Wall St. Rank hold NAUT as of Q3 2026.

GAMMA Investing held 3,547 shares of Nautilus Biotechnolgy worth $5.04K as of Q3 2026.
Nautilus Biotechnolgy was a new GAMMA Investing position in Q3 2026.
Nautilus Biotechnolgy made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3643 holding.
GAMMA Investing first reported a position in Nautilus Biotechnolgy in Q4 2023 and has held it in 4 quarters since.
2 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.